Join the KinaBot V1 Pilot: Speech and language-based cognitive wellness reflection.
A consent-based pilot that helps users reflect on speech and language feature trends over time. It is not a medical device, not a diagnostic tool, 
and does not provide dementia risk prediction or treatment recommendations.

About AIMOJI

Founded in July 2023 in New York State. In 2024, we relocated to Palo Alto, California, and are now actively expanding our business with support from JETRO San Francisco.

Our flagship product, KinaBot, a brain health barometer, that analyzes your voice and words from daily conversation, using score to monitor decline.

Speech-based Non-medical solution

Contact us